Your browser doesn't support javascript.
loading
HIV, syphilis, and hepatitis B virus infection and male circumcision in five Sub-Saharan African countries: Findings from the Population-based HIV Impact Assessment surveys, 2015-2019.
Peck, Megan E; Bronson, Megan; Djomand, Gaston; Basile, Ikuzo; Collins, Kamanzi; Kankindi, Ida; Kayirangwa, Eugenie; Malamba, Samuel S; Mugisha, Veronicah; Nsanzimana, Sabin; Remera, Eric; Kazaura, Kokuhumbya J; Amuri, Mbaraka; Mmbando, Susan; Mgomella, George S; Simbeye, Daimon; Colletar Awor, Anna; Biraro, Samuel; Kabuye, Geoffrey; Kirungi, Wilford; Chituwo, Omega; Hanunka, Brave; Kamboyi, Royd; Mulenga, Lloyd; Musonda, Bupe; Muyunda, Brian; Nkumbula, Tepa; Malaba, Rickie; Mandisarisa, John; Musuka, Godfrey; Peterson, Amy E; Toledo, Carlos.
Affiliation
  • Peck ME; Division of Global HIV & TB, HIV Prevention Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.
  • Bronson M; Division of Global HIV & TB, Epidemiology and Surveillance Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.
  • Djomand G; Division of Global HIV & TB, HIV Prevention Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.
  • Basile I; Ministry of Health, Rwanda Biomedical Center, Kigali City, Rwanda.
  • Collins K; ICAP at Columbia University, Kigali City, Rwanda.
  • Kankindi I; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Kigali, Rwanda.
  • Kayirangwa E; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Kigali, Rwanda.
  • Malamba SS; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Kigali, Rwanda.
  • Mugisha V; ICAP at Columbia University, Kigali City, Rwanda.
  • Nsanzimana S; Ministry of Health, Rwanda Biomedical Center, Kigali City, Rwanda.
  • Remera E; Ministry of Health, Rwanda Biomedical Center, Kigali City, Rwanda.
  • Kazaura KJ; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
  • Amuri M; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
  • Mmbando S; National AIDS Control Program, Ministry of Health, Dar-es-Salaam, Tanzania.
  • Mgomella GS; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
  • Simbeye D; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Dar-es-Salaam, Tanzania.
  • Colletar Awor A; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Biraro S; Columbia University, Kampala, Uganda.
  • Kabuye G; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Kirungi W; Ministry of Health, Kampala, Uganda.
  • Chituwo O; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Hanunka B; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Kamboyi R; Department of Public Health, Ministry of Health, Lusaka, Zambia.
  • Mulenga L; Department of Public Health, Ministry of Health, Lusaka, Zambia.
  • Musonda B; Department of Public Health, Ministry of Health, Lusaka, Zambia.
  • Muyunda B; Division of Global HIV & TB, Centers for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Nkumbula T; ICAP at Columbia University, Lusaka, Zambia.
  • Malaba R; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe.
  • Mandisarisa J; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe.
  • Musuka G; ICAP at Columbia University, Harare, Zimbabwe.
  • Peterson AE; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe.
  • Toledo C; Division of Global HIV & TB, HIV Prevention Branch, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States of America.
PLOS Glob Public Health ; 3(9): e0002326, 2023.
Article de En | MEDLINE | ID: mdl-37721926
ABSTRACT
Voluntary medical male circumcision (VMMC) has primarily been promoted for HIV prevention. Evidence also supports that male circumcision offers protection against other sexually transmitted infections. This analysis assessed the effect of circumcision on syphilis, hepatitis B virus (HBV) infection and HIV. Data from the 2015 to 2019 Population-based HIV Impact Assessments (PHIAs) surveys from Rwanda, Tanzania, Uganda, Zambia, and Zimbabwe were used for the analysis. The PHIA surveys are cross-sectional, nationally representative household surveys that include biomarking testing for HIV, syphilis and HBV infection. This is a secondary data analysis using publicly available PHIA data. Univariate and multivariable logistic regression models were created using pooled PHIA data across the five countries to assess the effect of male circumcision on HIV, active and ever syphilis, and HBV infection among sexually active males aged 15-59 years. Circumcised men had lower odds of syphilis infection, ever or active infection, and HIV, compared to uncircumcised men, after adjusting for covariates (active syphilis infection = 0.67 adjusted odds ratio (aOR), 95% confidence interval (CI), 0.52-0.87, ever having had a syphilis infection = 0.85 aOR, 95% CI, 0.73-0.98, and HIV = 0.53 aOR, 95% CI, 0.47-0.61). No difference between circumcised and uncircumcised men was identified for HBV infection (P = 0.75). Circumcised men have a reduced likelihood for syphilis and HIV compared to uncircumcised men. However, we found no statistically significant difference between circumcised and uncircumcised men for HBV infection.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies Langue: En Journal: PLOS Glob Public Health Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies Langue: En Journal: PLOS Glob Public Health Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique